Not medical advice. This site is general information only. In an emergency call your local emergency number. For advice about your own health, speak to a doctor, pharmacist or other qualified health professional.

Dolutegravir

Antiviral2013
Drug ClassAntiviral
Year Approved2013
Conditions TreatedHIV
AvailabilityPrescription

About Dolutegravir

An integrase strand transfer inhibitor or INSTI that is a first line HIV treatment. Dolutegravir or Tivicay blocks HIV integrase, preventing the virus from inserting its DNA into human cells. It is highly effective with a high genetic barrier to resistance. Dolutegravir is now the preferred first line HIV medication worldwide. WHO recommends dolutegravir based regimens for all adults and children. The drug has transformed HIV treatment with its potency and simplicity.

Related Medications